Avion Pharmaceuticals, LLC, announces the signing of a commercial license agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) for the development and commercialization of four Captisol-enabled programs. Under the terms of the...
WASHINGTON (dpa-AFX) - BGMedicine Inc. (BGMD) plunged over 22 percent on
Thursday after the company reported nearly a 26% drop in its Q2 revenues.
The company has two commercial products - Galectin-3 ELISA blood test and
By Trevor Lowenthal:
Several weeks ago, I wrote a bullish article on Ligand (NASDAQ:LGND), with a thesis stating that the company's outlook should improve with increasing royalty payments and new collaborations via its Captisol technology...
Lemelson Capital short stake built as share price collapses on insolvency and bankruptcy risk
Rev. Fr. Emmanuel Lemelson, Founder and President of the Lantern Foundation and Chief Investment Officer of Lemelson Capital Management,...
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29%2C+Avion+Pharma+Enter+Commercial+Licensing+Arrangement+Covering+Captisol-Enabled+Programs/9752653.html for the full story.
Lemelson Capital chief investment officer Emmanuel Lemelson recently increased his short position in Ligand Pharmaceuticals (NYSE: LGND) after its second quarter earnings report.
“Any company whose EPS is down 76 percent year over year while...
By Gregory M. Lemelson:
Lemelson Capital further increases short stake and reaffirms 100 percent downside risk in Ligand Pharmaceuticals (NASDAQ: LGND), revenue and earnings down across the board, while liabilities and dilution continue to rise...
Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)
Q2 2014 Results Earnings Conference Call
August 04, 2014 09:00 AM ET
Erika Luib - Investor Relations
John Higgins- President and CEO
Matt Foehr - EVP and COO
Nishan DeSilva -...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Ligand Pharmaceuticals (LGND):